Cases 21 - 30 of 871
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HAUGHTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03646
Plaintiff:
OCIE MAE HAUGHTON
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ARROW PHARM (MALTA) LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FANNING v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03540
Plaintiff:
LINDA FANNING
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FWK HOLDINGS, LLC. v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02958
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
FWK Holdings LLC
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
MLI RX LLC et al v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02960
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
MLI RX LLC, AMERISOURCEBERGEN CORP., AMERISOURCEBERGEN DRUG CORP. and others
Interested Party:
GlaxoSmithKline LLC
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
MORRIS & DICKSON CO., L.L.C. v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02956
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
MORRIS & DICKSON CO., L.L.C.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
BUXTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02933
Plaintiff:
DIXIE B BUXTON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MERRILL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02857
Plaintiff:
DOUGLAS MERRILL
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WESSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02342
Plaintiff:
EMMETT WESSON
Defendant:
AUROBINDO PHARMA LTD., HETERO DRUGS LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
